Entry Point Capital, LLC Legend Biotech Corp Transaction History
Entry Point Capital, LLC
- $68.4 Billion
- Q2 2024
A detailed history of Entry Point Capital, LLC transactions in Legend Biotech Corp stock. As of the latest transaction made, Entry Point Capital, LLC holds 2,850 shares of LEGN stock, worth $116,707. This represents 0.18% of its overall portfolio holdings.
Number of Shares
2,850
Previous 176
1519.32%
Holding current value
$116,707
Previous $9.87 Million
1178.64%
% of portfolio
0.18%
Previous 0.01%
Shares
2 transactions
Others Institutions Holding LEGN
# of Institutions
202Shares Held
74.3MCall Options Held
371KPut Options Held
387K-
Price T Rowe Associates Inc Baltimore, MD11.5MShares$470 Million0.06% of portfolio
-
Ra Capital Management, L.P. Boston, MA7.51MShares$307 Million5.01% of portfolio
-
Hhlr Advisors, Ltd. Grand Cayman, E96.64MShares$272 Million7.6% of portfolio
-
Black Rock Inc. New York, NY5.72MShares$234 Million0.01% of portfolio
-
Westfield Capital Management CO LP Boston, MA4.77MShares$195 Million1.06% of portfolio
About Legend Biotech Corp
- Ticker LEGN
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 167,403,008
- Market Cap $6.86B
- Description
- Legend Biotech Corporation, a clinical-stage biopharmaceutical company, through its subsidiaries, engages in the discovery and development of novel cell therapies for oncology and other indications in the United States, China, and internationally. Its lead product candidate, LCAR- B38M, is a chimeric antigen receptor for the treatment of multipl...